Centiva Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-128,544
Closed -$5.06M 2266
2023
Q2
$5.06M Buy
+128,544
New +$4.54M 0.11% 178
2022
Q4
Sell
-14,398
Closed -$259K 1751
2022
Q3
$259K Buy
+14,398
New +$189K ﹤0.01% 1097

Centiva Capital's ISEE Position: Q3 2023 in Review

Centiva Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 128,544 shares — an estimated $5.06M sold.

Centiva Capital first reported a position in ISEE in Q3 2022 and held it in 2 quarters. The position peaked at $5.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Centiva Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Centiva Capital sold 128,544 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.06M.
  • Centiva Capital first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Centiva Capital's IVERIC bio, Inc. Common Stock position peaked at $5.06M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.